Targeted DNA RNA Sequencing Market Size, Share, Trends, Growth Outlook

Targeted DNA RNA Sequencing Market is estimated to increase at a growth rate of 14.8% CAGR over the forecast period from 2024 to 2030.

The global Targeted DNA RNA Sequencing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Technology (NGS By Method (Exome Sequencing, Enrichment Sequencing, Amplicon Sequencing), NGS By Application (Cancer Gene Sequencing, Inherited Disease Screening, Drug Development, Forensic Genomics, 16S ribosomal RNA (rRNA) sequencing, Others)), By Workflow (Pre-sequencing, Sequencing, Data Analysis), By Application (Human Biomedical Research, Plant & Animal Sciences, Drug Discovery, Others), By Type (DNA Based Targeted Sequencing, RNA Based Targeted Sequencing), By End-user (Academic Research, Hospitals & Clinics, Pharma & Biotech Entities, Others).

An introduction to Targeted DNA RNA Sequencing Market in 2024

The targeted DNA/RNA sequencing market is experiencing notable growth in 2024, driven by advancements in next-generation sequencing (NGS) technologies, molecular diagnostics, and the growing adoption of precision medicine approaches in oncology, inherited disorders, and infectious diseases. Targeted DNA/RNA sequencing, also known as gene panel sequencing or amplicon sequencing, enables selective amplification and sequencing of specific genomic regions or gene targets, allowing researchers, clinicians, and molecular biologists to analyze genetic variations, identify disease-causing mutations, and personalize treatment strategies based on individual genetic profiles. With innovations in target enrichment methods, library preparation kits, and bioinformatics pipelines, the market is witnessing rapid expansion and adoption of targeted sequencing technologies, offering academic research labs, clinical laboratories, and biotech companies scalable and cost-effective solutions for genetic testing, variant discovery, and disease diagnostics, driving advancements in molecular diagnostics and genomic medicine applications.

Targeted DNA RNA Sequencing Market Trend: Rise in Personalized Medicine and Precision Oncology:

A significant trend in the Targeted DNA RNA Sequencing Market is the rise in personalized medicine and precision oncology. With advancements in genomic sequencing technology and bioinformatics, there's a growing adoption of targeted DNA RNA sequencing for the molecular profiling of tumors and the identification of actionable genetic alterations in cancer patients. This trend is driven by the need for precise and individualized treatment strategies based on the genetic characteristics of tumors, enabling oncologists to select targeted therapies, predict treatment response, and optimize patient outcomes. Healthcare providers are increasingly incorporating targeted sequencing into clinical practice to guide treatment decisions and improve the efficacy of cancer therapy, thus driving market growth as the demand for personalized oncology solutions continues to rise.

Targeted DNA RNA Sequencing Market Driver: Increase in Cancer Incidence and Genomic Research:

The increase in cancer incidence and genomic research serves as a major driver for the Targeted DNA RNA Sequencing Market. As the global burden of cancer continues to grow and the understanding of cancer biology expands, there's a heightened focus on elucidating the genomic landscape of tumors and identifying novel therapeutic targets. Targeted DNA RNA sequencing enables comprehensive profiling of cancer genomes, transcriptomes, and epigenomes, providing valuable insights into the molecular mechanisms of cancer progression and treatment resistance. This trend is fueling market growth as academic institutions, research organizations, and pharmaceutical companies invest in genomic studies and clinical trials to discover biomarkers, develop targeted therapies, and advance precision medicine approaches for cancer patients.

Targeted DNA RNA Sequencing Market Opportunity: Expansion into Non-Oncology Applications and Rare Diseases:

An opportunity exists for market expansion through the expansion into non-oncology applications and rare diseases. With the increasing adoption of targeted sequencing technology and the growing understanding of genetic factors underlying various diseases, there's potential to broaden the scope of targeted DNA RNA sequencing beyond oncology to other therapeutic areas such as rare diseases, genetic disorders, and infectious diseases. Manufacturers can develop targeted sequencing panels and assays tailored to specific disease indications, offering comprehensive genomic profiling solutions for clinical diagnostics, drug discovery, and patient management. By entering non-oncology markets and addressing unmet needs in rare diseases, companies can diversify their product portfolios, tap into new revenue streams, and contribute to advancements in precision medicine across a wide range of medical specialties, thus unlocking new growth opportunities in the Targeted DNA RNA Sequencing Market. This strategic opportunity aligns with the broader trend towards personalized healthcare and genomic medicine, addressing the evolving needs of clinicians and researchers for advanced sequencing solutions that enable comprehensive molecular characterization and tailored therapeutic interventions.

Targeted DNA RNA Sequencing Market Market Segmentation

By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Targeted DNA RNA Sequencing Market Companies

Agilent Technologies Inc
ArcherDX Inc
BGI Group
Illumina Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc

Reasons to Buy the Targeted DNA RNA Sequencing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Targeted DNA RNA Sequencing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Targeted DNA RNA Sequencing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Targeted DNA RNA Sequencing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Targeted DNA RNA Sequencing Market Size Outlook, $ Million, 2021 to 2030
3.2 Targeted DNA RNA Sequencing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Targeted DNA RNA Sequencing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Targeted DNA RNA Sequencing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Targeted DNA RNA Sequencing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Targeted DNA RNA Sequencing Industry
4.2 Key Market Trends in Targeted DNA RNA Sequencing Industry
4.3 Potential Opportunities in Targeted DNA RNA Sequencing Industry
4.4 Key Challenges in Targeted DNA RNA Sequencing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Targeted DNA RNA Sequencing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Targeted DNA RNA Sequencing Market Outlook by Segments
7.1 Targeted DNA RNA Sequencing Market Outlook by Segments, $ Million, 2021- 2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

8 North America Targeted DNA RNA Sequencing Market Analysis and Outlook To 2030
8.1 Introduction to North America Targeted DNA RNA Sequencing Markets in 2024
8.2 North America Targeted DNA RNA Sequencing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Targeted DNA RNA Sequencing Market size Outlook by Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

9 Europe Targeted DNA RNA Sequencing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Targeted DNA RNA Sequencing Markets in 2024
9.2 Europe Targeted DNA RNA Sequencing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Targeted DNA RNA Sequencing Market Size Outlook by Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

10 Asia Pacific Targeted DNA RNA Sequencing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Targeted DNA RNA Sequencing Markets in 2024
10.2 Asia Pacific Targeted DNA RNA Sequencing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Targeted DNA RNA Sequencing Market size Outlook by Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

11 South America Targeted DNA RNA Sequencing Market Analysis and Outlook To 2030
11.1 Introduction to South America Targeted DNA RNA Sequencing Markets in 2024
11.2 South America Targeted DNA RNA Sequencing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Targeted DNA RNA Sequencing Market size Outlook by Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

12 Middle East and Africa Targeted DNA RNA Sequencing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Targeted DNA RNA Sequencing Markets in 2024
12.2 Middle East and Africa Targeted DNA RNA Sequencing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Targeted DNA RNA Sequencing Market size Outlook by Segments, 2021-2030
By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Agilent Technologies Inc
ArcherDX Inc
BGI Group
Illumina Inc
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
QIAGEN N.V.
Roche Holding AG
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Technology
NGS By Method
-Exome Sequencing
-Enrichment Sequencing
-Amplicon Sequencing
NGS By Application
-Cancer Gene Sequencing
-Inherited Disease Screening
-Drug Development
-Forensic Genomics
-16S ribosomal RNA (rRNA) sequencing
Others
By Workflow
Pre-sequencing
Sequencing
Data Analysis
By Application
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
By Type
DNA Based Targeted Sequencing
RNA Based Targeted Sequencing
By End-User
Academic Research
Hospitals & Clinics
Pharma & Biotech Entities
Others